This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on July 6, 2024.
Return to the list of Patented Medicine Litigation page.
Lisdexamfetamine
VYVANSE, VYVANSEORA – SHIRE PHARMA CANADA ULC (NOC Search)
Patents:
- 2527646: APOTEX
APOTEX
- PM(NOC) – T-641-18 – T-723-16 – T-816-16 – T-998-16
- Impeachment – T-1056-16 (2016 FC 1267, 2016 FC 1099, 2017 FC 831, 2017 FC 139, 2018 FC 637, 2018 FC 1106)
- Appeal – A-283-18 – A-390-18 (2021 FCA 54) – A-391-18
Return to the Patented Medicine Litigation page.